Antagonism of EGFR and HER3 Enhances the Response to Inhibitors of the PI3K-Akt Pathway in Triple-Negative Breast Cancer
Science Signaling - United States
doi 10.1126/scisignal.2005125
Full Text
Open PDFAbstract
Available in full text
Date
March 25, 2014
Authors
Publisher
American Association for the Advancement of Science (AAAS)